News & Events
Phytolon Closes $23.6 Million Series B to Commercialize its Innovative Natural Food Colors
Earlier this year the FDA approved 'Beetroot Red', Phytolon's first product made by fermentation; the effective date is subject to FDA procedures
26 May 2026
Phytolon, a biotechnology company pioneering fermentation-based natural color solutions announces the close of its $23.6 Million Series B financing to commercialize its natural food colors in the US. This round reflects growing market demand for high-performing, economic, and sustainable natural alternatives to synthetic dyes.
This round was led by an undisclosed strategic investor. The funds were secured during three stages. Most of the funds were secured in the last stage in April, with participation from existing investors, including NextGen Nutrition (NGN), Colorcon Ventures, Millennium Foodtech, and Yossi Ackerman.
The financing follows the FDA approval of Beetroot Red, the company’s first natural colorant in its portfolio (an effective date of the final ruling is yet to be set). Beetroot Red complies with the required standards of performance and clean label that CPGs and consumers expect in the modern food markets. Produced via fermentation of baker’s yeast, Beetroot Red is an elevated natural color rooted in cost efficiency, robust supply, and environmental sustainability.
This news was also published here: PRNewswire, GreenQueen Media, Food Ingredients First, CTech
Hebrew publications: Calcalist, Funder, Geektime, Bizportal
This new funding will be allocated to support sales and supply to CPGs and to distribution partners in the US and beyond. I am excited to see our portfolio of strategic investors increase, enabling us to grow our business and establish our footprint in the market.
Halim Jubran, Phytolon’s Co-Founder and CEO
Phytolon is at the nexus two mega-trends — consumer and regulatory demand to remove artificial dyes and advances in fermentation to offer natural ingredients with better functionality, cost and sustainability. With a strong network of strategic partners and recent FDA approval, Phytolon is well positioned to capitalize on the transition toward natural dyes across food and supplements products.
James Cali, General Partner at NGN
See More News
Escala Secures $4.5M in Funding to Accelerate Global Expansion of Its FDA-Approved Medical Device
Co-financing by the EIC Fund to ramp up women’s health solution to POP
Phytolon Secures Funding from Rich Products Ventures to Bring Natural Food Colors to Market
